Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 21:5:22.
doi: 10.1186/s40249-016-0115-z.

Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia

Mahteme Haile Workneh  1   2 , Gunnar Aksel Bjune  3 , Solomon Abebe Yimer  3   4   5   6
Affiliations

Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia

Mahteme Haile Workneh et al. Infect Dis Poverty. .

Abstract

Background: There is growing evidence suggesting that diabetes mellitus (DM) affects disease presentation and treatment outcome in tuberculosis (TB) patients. This study aimed at investigating the role of DM on clinical presentations and treatment outcomes among newly diagnosed TB patients.

Methods: A prospective cohort study was conducted in South-Eastern Amhara Region, Ethiopia from September 2013 till March 2015. Study subjects were consecutively recruited from 44 randomly selected health facilities in the study area. Participants were categorized into two patient groups, namely, patients with TB and DM (TBDM) and TB patients without DM (TBNDM). Findings on clinical presentations and treatment outcomes were compared between the two patient groups. Cox proportional hazard regression analysis was applied to identify factors associated with death.

Results: Out of 1314 TB patients enrolled in the study, 109 (8.3 %) had coexisting DM. TBDM comorbidity [adjusted hazard ratio (AHR) 3.96; 95 % confidence interval (C.I.) (1.76-8.89)], and TB coinfection with human immunodeficiency virus (HIV) [AHR 2.59; 95 % C.I. (1.21-5.59)] were associated with increased death. TBDM and TBNDM patients did not show significant difference in clinical symptoms at baseline and during anti-TB treatment period. However, at the 2(nd) month of treatment, TBDM patients were more symptomatic compared to patients in the TBNDM group.

Conclusions: The study showed that DM is associated with increased death during TB treatment. DM has no association with clinical presentation of TB except at the end of the intensive phase treatment. Routine screening of TB patients for DM is recommended for early diagnosis and treatment of patients with TBDM comorbidity.

Keywords: Amhara Region; Association; Diabetes mellitus; Ethiopia; Symptoms; Treatment outcome; Tuberculosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Kaplan-Meier curves for sputum smear conversion comparing TBDM Vs. TBNDM patient groups
Fig. 2
Fig. 2
Kaplan-Meier curves for death comparing TBDM Vs. TBNDM patient groups
See this image and copyright information in PMC

References

    1. Niazi AK, Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. J Diabetes Metab Disord. 2012;11:28. doi: 10.1186/2251-6581-11-28. - DOI - PMC - PubMed
    1. World Health Organization. Global tuberculosis report. 2013. http://apps.who.int/iris/bistream/10665/91355/1/9789241564656_eng.pdf. Accessed 7 Aug 2014.
    1. Das P, Horton R. Tuberculosis-time to accelerate progress. The Lancet. 2010; 375(9718):1755–57. - PubMed
    1. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Soc Sci Med. 2009;68:2240–6. doi: 10.1016/j.socscimed.2009.03.041. - DOI - PubMed
    1. Dooely KE, Chaisson RE. Tuberculosis and diabetes mellitus: Convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737–46. doi: 10.1016/S1473-3099(09)70282-8. - DOI - PMC - PubMed

Publication types

Substances